Contraceptive Technology Update – June 1, 2014
June 1, 2014
View Issues
-
Retention of patients is critical to family planning financial sustainability
A new free resource, Patient Experience Improvement Toolkit: A Guide for Family Planning, is available to help family planning agencies develop patient experience goals; measure and use patient experience data; enhance interpersonal skills; and improve clinic sites, online and offline. -
Check digital trends in STI prevention
The Internet and the cell phone are helping patients in not only seeking testing for sexually transmitted infections (STIs), but learning their test results and promoting treatment for themselves and their partners. -
Accelerate HPV vaccine uptake: Time to move
A new report emphasizes the need to energize efforts to reach the potential of human papillomavirus (HPV) vaccines to save lives and prevent millions of avoidable cancers and HPV-related conditions in men and women. -
Diaphragm: Update on this barrier contraceptive
The female diaphragm offers hormone-free contraception that is female-initiated and female-controlled. Currently available diaphragms require a pelvic examination and fitting to ensure proper size and placement of the device. -
Teratogenic drug use: Check contraception
About 1.7 million women of childbearing age are prescribed Food and Drug Administration Category D or Category X medications each year. However, despite label warnings, about 6% of U.S. pregnancies occur in women taking medications with known teratogenic risk. -
Quick Start: Why put off what you can do today?
For the last 15 years, emerging evidence has encouraged clinicians who prescribe hormonal contraception to quick start patients on their chosen contraceptive method on the day of the visit, instead of waiting until after menses begins.